The Death of the Cigarette, According to Big Tobacco
Philip Morris International, the company that made Marlboro a global icon, now wants cigarettes extinct. The CEO said publicly that cigarettes "belong in a museum" as the company accelerates its pivot to smoke-free products like Zyn nicotine pouches and IQOS heated tobacco devices. For a business built on combustible tobacco for over a century, this isn't just marketing spin — it's a complete strategic reversal driven by regulation and declining smoking rates in developed markets.
The Military Exception: Where Smoking Rates Stay Stubbornly High
While U.S. tobacco use overall has been declining, one population remains stuck in the past: military members and veterans. More than 1 in 5 veterans smoke cigarettes, significantly above the national average, according to CDC data. The military has what experts call an "entrenched culture of tobacco use" — smoking breaks bond units, deployment stress drives nicotine dependence, and cigarettes remain cheap on military bases. Cigarettes are still the number one preventable cause of death in the United States, and veterans are dying from it at disproportionate rates.
Harm Reduction or Just New Packaging?
Multiple experts speaking at a Hill event on Tuesday framed smokeless nicotine products as a "bridge" for service members trying to quit cigarettes. A vascular and interventional radiologist who has treated smoking-related disease throughout his career noted that switching from combustibles to heated tobacco or pouches can reduce exposure to the toxins created by burning tobacco. Philip Morris argues that "eliminating combustion dramatically reduces harm" — a claim that has regulatory backing in some markets but remains controversial in public health circles.
The company's shift is real: Zyn and IQOS are surging in sales while cigarette volumes decline. But public health experts warn that long-term effects of these products remain uncertain, and addiction risks persist. Nicotine is still nicotine, whether it's smoked, heated, or tucked in a pouch. The question facing regulators and prediction markets alike is whether this represents genuine harm reduction or just Big Tobacco reinventing itself for a new generation of addicts.
What Traders Should Watch
The tobacco industry's transformation creates divergent market opportunities. Companies successfully transitioning to smoke-free products could see regulatory tailwinds and demographic shifts work in their favor. But the military and veteran population — a historically profitable customer segment — represents a lagging indicator. If Philip Morris and its competitors can crack the veteran smoking problem with pouches and heated tobacco, it validates the entire harm reduction thesis. If not, it suggests these products are capturing new users rather than converting existing smokers, which would trigger a regulatory backlash. Watch for FDA guidance on nicotine pouch marketing and any DoD policy changes around tobacco sales on military installations.